Targeting Multiplicity: The Key Factor for Anti-Cancer Nanoparticles

被引：11

作者：

Gary-Bobo, M. ^{[1
,4
]}

Vaillant, O. ^{[1
]}

Maynadier, M. ^{[1
]}

Basile, I. ^{[1
]}

Gallud, A. ^{[1
]}

El Cheikh, K. ^{[1
]}

Bouffard, E. ^{[1
]}

Morere, A. ^{[1
,4
]}

Rebillard, X. ^{[1
,2
]}

Puche, P. ^{[1
,3
]}

Nirde, P. ^{[1
]}

Garcia, M. ^{[1
,4
]}

机构：

[1] CNRS, Inst Biomol Max Mousseron, UMR 5247, UM1,UM2, F-34093 Montpellier 05, France

[2] Clin Mutualiste Beau Soleil, Serv Urol, F-34070 Montpellier, France

[3] Hop St Eloi, Serv Medicochirurg Malad Appareil Digestif & Tran, Montpellier 5, France

[4] NanoMedSyn, F-34093 Montpellier 05, France

来源：

CURRENT MEDICINAL CHEMISTRY | 2013年 / 20卷 / 15期

关键词：

Cancer; multiple targeting; nanoparticles; non-invasive therapies; MESOPOROUS SILICA NANOPARTICLES; 2-PHOTON PHOTODYNAMIC THERAPY; IRON-OXIDE NANOPARTICLES; CARBONIC-ANHYDRASE-IX; BREAST-CANCER CELLS; DRUG-DELIVERY; POLYMERIC NANOPARTICLES; CONTRAST AGENT; ENHANCED MRI; BLOOD-FLOW;

D O I：

10.2174/0929867311320150002

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

In this mini-review, we focus on different strategies to bring nanotools specifically to cancer cells. We discuss about a better targeting of tumor, combining the characteristics of tumor environment, the increase in nanoparticles life time, the biomarkers overexpressed on cancer cells and different physical methods for non invasive therapies. Here we detail the necessity of a synergy between passive and active targeting for an actual specificity of cancer cells.

引用

页码：1946 / 1955

页数：10

共 50 条

[1] Zoledronic acid - a multiplicity of anti-cancer action
Yuasa, Takeshi
Kimura, Shinya
Ashihara, Eishi
Habuchi, Tomonori
Maekawa, Taira
[J]. CURRENT MEDICINAL CHEMISTRY, 2007, 14 (20) : 2126 - 2135
[2] Optimization of anti-cancer drugs and a targeting molecule on multifunctional gold nanoparticles
Rizk, Nahla
Christoforou, Nicolas
Lee, Sungmun
[J]. NANOTECHNOLOGY, 2016, 27 (18)
[3] Application of Nanoparticles with Targeting, Triggered Release in Anti-Cancer Drug Delivery
Zhang Lei
Liu Xiaoyan
Shen Jingjing
Lu Xiaomei
Fan Quli
Huang Wei
[J]. PROGRESS IN CHEMISTRY, 2013, 25 (08) : 1375 - 1382
[4] Targeting epidermal growth factor receptor positive breast cancer using nanoparticles loaded with the anti-cancer drug aminoflavone
Brinkman, Ashley M.
Chen, Guojun
Sherer, Nathan
Gong, Shaoqin
Xu, Wei
[J]. CANCER RESEARCH, 2014, 74 (19)
[5] The complexities of tumor associated macrophages and the key to effective targeting for anti-cancer therapy
Guerriero, Jennifer L.
[J]. CANCER IMMUNOLOGY RESEARCH, 2022, 10 (12)
[6] The complexities of tumor associated macrophages and the key to effective targeting for anti-cancer therapy
Guerriero, Jennifer L.
[J]. CANCER RESEARCH, 2023, 83 (07)
[7] Targeting Anti-Cancer Agents and Cancer Treatments
Sun, Lichun
[J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2015, 15 (07) : 806 - 808
[8] Targeting Mitosis for Anti-Cancer Therapy
Valery Sudakin
Timothy J. Yen
[J]. BioDrugs, 2007, 21 : 225 - 233
[9] MCAB TARGETING ANTI-CANCER DRUGS
BALDWIN, RW
[J]. BRITISH JOURNAL OF CANCER, 1984, 50 (04) : 561 - 562
[10] Targeting Phosphatidylserine in Anti-Cancer Therapy
Kenis, Heidi
Reutelingsperger, Chris
[J]. CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (23) : 2719 - 2723

← 1 2 3 4 5 →